Professor Stephen Riordan
Gastroenterology and the Liver
MBBS (Hons), MD (UNSW), FRACP, FRCP (London)
Scientific Publications
| 165. | Commensal gut microbiota, genetic and epigenetic factors and susceptibility to inflammatory bowel disease. Microbiology Australia 2013; 151-152. |
| 166. | The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS ONE/Public Library of Science 2013; 8: e75525. |
| 167. | Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease. Journal of Gastroenterology and Hepatology 2013; 28(Suppl. 2): 67. |
| 168. | The association between a tight junction toxin gene in Campylobacter concisus and inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2013; 28(Suppl. 2): 14. |
| 169. | An extended review of therapeutic appendicectomy in ulcerative colitis, American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, San Diego, October 2013. |
| 170. | Campylobacter concisus and inflammatory bowel disease. World Journal of Gastroenterology 2014; 20: 1259-1267. |
| 171. | Interferon lambda 3 haplotype affects treatment response to interferon-alpha and ribavirin combination therapy in chronic hepatitis C. Nature Genetics 2009; 41: 1100-1104. |
| 172. | Overgrowth of the indigenous gut microbiome and irritable bowel syndrome. World Journal of Gastroenterology 2014; 20: 2449-2455. |
| 173. | Examination of the anaerobic growth of Capylobacter concisus strains. International Journal of Microbiology 2014; 2014: 476047. |
| 174. | The interplay between Campylobacter and Helicobacter species and other gastrointestinal microbiota of commercial broiler chickens. Gut Pathogens 2014, 6: 18. |
| 175. | Investigation of the effects of pH and bile on the growth of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease and controls. Journal of Medical Microbiology 2014; In press |
| 176. | ENABLE-ALL: Safety and efficacy of eltrombopag in thrombocytopenic hepatitis C virus-infected patients with cirrhosis who withdrew from the ENABLE-1 & -2 studies. The 24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Brisbane, March 2014. |
| 177. | The effects of gastrointestinal factors on Campylobacter concisus growth. Journal of Gastroenterology and Hepatology 2014; 29(Suppl. 2): 22. |
| 178. | Polymorphisms in C. concisus Zot affect the cleavage of Zot proteins by bacterial proteases. Journal of Gastroenterology and Hepatology 2014; 29(Suppl. 2): 25. |